Authors:
Kiran Pulidindi, Kunal Ahuja
Download free PDF
Rice Starch Market Size & Share 2026-2035
Report ID: GMI14212
|
Published Date: October 2026
|
Report Format: PDF/Excel/Dashboard/Platform
Explore Our Licensing Options:
Rice Starch Market
Get a free sample of this report
What are you hoping to find?
Your PDF is on its way. Tell us little about your research goal, and we'll help you find the most relevant market insights.
Rice Starch Market Size
The Rice Starch Market was valued at USD 878 million in 2025, is projected to reach USD 939 million in 2026, and is expected to expand at 7.3% CAGR (2026-2035) to USD 1.76 billion by 2035.
Rice Starch Market Key Takeaways
Market Leader: Ingredion Inc. led with over 11% market share in 2025.
Leading Players: Top 5 players in this market include Ingredion Inc., BENEO GmbH, JiangXi Golden Agriculture Biotech, Bangkok Starch Industrial Co. Ltd., Cargill Inc., which collectively held a market share of 33% in 2025.
The rice starch market covers demand-side revenue and volume associated with native and modified starches derived from *Oryza sativa* for food, pharmaceutical, cosmetics, paper, textile, packaging, and industrial use. Growth is being shaped by clean-label reformulation, demand for hypoallergenic functional ingredients, and the expanding use of specification-grade starches where traceability, processing performance, and compliance documentation influence purchasing decisions.
GMI Analyst View
Based on our primary research with industry participants, rice starch demand reached 1,050 thousand metric tonnes in 2025. This volume trajectory reflects sustained intake from Asia-Pacific food processors and rising pharmaceutical excipient procurement, and it anchors GMI's confidence in the market's compound revenue growth outlook through 2035.
Rice Starch Market Trends, Growth Drivers & GMI Forecast Outlook
Clean-label ingredient substitution and pharmaceutical-grade excipient demand are expected to move rice starch consumption toward higher-value applications, while raw-material volatility and lower-cost starch alternatives will continue to constrain commodity-grade pricing and volume capture. The resulting outlook depends on suppliers' ability to combine functional performance with credible sourcing and compliance capabilities.
Key Drivers
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
Clean-label reformulation is increasing the importance of starches that can provide texture, binding, and stability without introducing an ingredient profile that conflicts with allergen-free or natural-positioning claims. Rice starch is particularly relevant where manufacturers need a neutral sensory profile and an ingredient that can fit premium food, infant-nutrition, and personal care formulations. This demand favors suppliers able to maintain segregated sourcing, documentation, and consistent functional performance across batches.
Pharmaceutical use adds a different source of demand discipline. Tablet and oral-solid-dose manufacturers evaluate excipients on uniformity, process reproducibility, documentation, and qualification history, rather than on ingredient cost alone. As oral drug formats expand, demand should increasingly favor modified and pharmacopeially suitable rice starch grades that can support binding, disintegration, and controlled-release formulation requirements.
Biodegradable films, industrial adhesives, and functional-food formats create an additional route to demand diversification. These applications remain more technically and commercially selective than established food uses, but they broaden the addressable role of rice starch beyond conventional thickening and binding. Commercial adoption will depend on whether processors can meet performance specifications without undermining the cost position of finished products.
Key Restraints
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
Rice procurement exposure is a central margin issue because starch processing depends on a raw material whose availability and cost can be affected by weather conditions, trade measures, and regional supply concentration. The elevated FAO rice-price benchmark underscores the challenge for processors selling into applications where buyers can change starch inputs without compromising the finished product. Integrated sourcing, contracted supply relationships, and traceability programs can therefore become commercial advantages rather than merely operational safeguards.
Substitution pressure is strongest where rice starch is purchased primarily for basic thickening, viscosity management, or binding. Tapioca, corn, and other starches can be economically attractive when a buyer does not require rice-derived positioning, allergen-management credentials, or specialized functionality. This favors rice starch producers that can defend their offering through application support, validated product performance, and customer-specific qualification.
Regulatory fragmentation further separates capable suppliers from smaller exporters. A producer supplying regulated pharmaceutical or food applications must satisfy market-specific documentation, testing, and audit expectations before it can compete for qualified business. The associated time-to-market burden can restrict smaller firms' access to premium destinations even when they possess adequate processing capacity.
GMI Analyst View
We see the forecast increasingly turning on the quality of demand rather than on undifferentiated starch volume alone. Clean-label reformulation and pharmaceutical qualification both reward reliable performance, traceability, and regulatory readiness, creating a more favorable environment for suppliers positioned in specialty grades than for producers exposed primarily to commodity substitution.
Rice Starch Market Segment Analysis
By Product Type
Within the Rice Starch Market, native rice starch generated USD 483 million in 2025 and is projected to account for 51% of market revenue by 2035. Its position remains supported by established food-processing supply chains, familiar handling characteristics, and demand from applications where standard thickening, gelling, or binding functionality is sufficient. Modified rice starch is forecast to reach USD 868 million by 2035 and expand at 8.2% CAGR (2026-2035). Its stronger trajectory reflects growing customer requirements for cold-water solubility, heat resistance, acid stability, and processing consistency in convenience foods, pharmaceutical formulations, and specialty industrial applications.
By Nature
Conventional rice starch recorded USD 773 million in revenue in 2025 and is expected to retain 82% of market revenue by 2035. Its scale reflects its continued relevance to high-volume food processing, textile sizing, industrial use, and applications where organic certification does not materially influence procurement. Organic rice starch generated USD 105 million in 2025 and is projected to reach USD 318 million by 2035. Its expansion is tied to branded demand for certified ingredient chains in premium food, infant-nutrition, cosmetics, and personal care products, where chain-of-custody assurance and natural-origin positioning can support differentiated purchasing decisions.
By Application
Food & Beverage
Food & Beverage generated USD 421 million in 2025 and is projected to represent 47% of rice starch market revenue by 2035. The application benefits from rice starch's utility in sauces, bakery fillings, confectionery, dairy desserts, coatings, and infant-food formats. Demand is supported by manufacturers seeking stable texture and clean-label formulation options without relying exclusively on synthetic stabilizers or wheat-derived ingredients.
Pharmaceutical
Pharmaceutical revenue is projected to reach USD 406 million by 2035, growing at 7.7% CAGR (2026-2035). Rice starch is increasingly evaluated as a tablet binder, disintegrant, and carrier material where hypoallergenic positioning, particle consistency, and documented quality systems are important. The application's outlook is strengthened by demand for oral dosage formulations and by procurement preferences for qualified specialty excipients.
Cosmetics & Personal Care
Cosmetics & Personal Care generated USD 158 million in 2025 and is expected to reach USD 318 million by 2035. Fine-particle rice starch can provide oil absorption, skin feel, and texture benefits in face powders, dry shampoos, body powders, and skin-care products. Its role is particularly relevant where formulators are replacing talc or seeking plant-derived ingredients that align with natural and premium product positioning.
Paper & Packaging
Paper & Packaging is projected to hold 6% of market revenue by 2035 and grow at 5.8% CAGR (2026-2035). The application uses rice starch in surface sizing, coatings, and adhesive systems, but faces slower progression where digitalization limits certain paper categories and commodity alternatives remain competitively priced. Biodegradable packaging remains the principal opportunity capable of improving the segment's long-term demand profile.
Textile
Textile application generated USD 26 million in 2025 and is projected to reach USD 37 million by 2035. Rice starch remains relevant in selected warp-sizing and finishing applications, particularly where biodegradability or natural-input positioning matters. However, synthetic sizing agents continue to constrain broader adoption in high-volume textile manufacturing because of their established performance and cost characteristics.
Others
The Others category is expected to account for 4% of market revenue by 2035 and expand at 13.9% CAGR (2026-2035). Industrial adhesives, bioplastics, animal-feed binders, and functional-food formats provide the principal sources of momentum. These uses are developing from a limited commercial base, making technical qualification, end-user trials, and scalable compounding capacity decisive to their contribution.
GMI Analyst View
We believe the most important segment shift is the movement from basic starch functionality toward applications where formulation performance and qualification requirements command a premium. Modified, organic, pharmaceutical, and cosmetic grades are increasingly interconnected through the same commercial attributes: reliable processing behavior, traceability, and the ability to meet more demanding customer specifications.
Rice Starch Market Regional Analysis
Asia Pacific Rice Starch Market Analysis
The Rice Starch Market in Asia Pacific accounted for 38% of global revenue in 2025 and is projected to reach USD 725 million by 2035. The region combines proximity to rice supply, substantial starch-processing capacity, and deep end-market demand from food manufacturing, pharmaceutical production, and cosmetics. This integrated position supports both domestic consumption and export-oriented specialty starch production.
China
China generated USD 120 million in 2025 and is projected to reach USD 255 million by 2035. Domestic food manufacturing demand and the continued expansion of higher-value processing support the country's role as both a large consuming market and a supply base for specialty rice-derived ingredients. Producers are increasingly positioned to serve export customers requiring more consistent functional and documentation standards.
Japan
Japan is expected to hold 14% of Asia Pacific revenue by 2035 and grow at 6.4% CAGR (2026-2035). Its mature food market supports stable demand, while pharmaceutical and premium cosmetics applications provide the more attractive specialty opportunities. Buyers place particular importance on product consistency and quality systems in these higher-value uses.
India
India generated USD 45 million in 2025 and is forecast to expand at 8.0% CAGR (2026-2035). The country's large rice base, food-processing expansion, and generic-drug manufacturing ecosystem support demand for both conventional and pharmaceutical-grade starches. Capacity investments may also improve India's position in export markets seeking diversified sourcing options.
South Korea
South Korea is projected to reach USD 68 million by 2035 and grow at 7.0% CAGR (2026-2035). Demand is supported by cosmetics formulation, branded pharmaceutical manufacturing, and the broader influence of Korean beauty products on natural and rice-derived ingredient preferences. Fine-particle and specialty grades are particularly relevant to these end uses.
Australia
Australia held 6% of Asia Pacific revenue in 2025 and is expected to reach USD 38 million by 2035. The market is largely demand-led, with food, health-product, and pharmaceutical manufacturers sourcing premium grades from regional suppliers. Clean-label and organic product development sustain demand for qualified imported ingredients.
Rest of Asia Pacific
Rest of Asia Pacific is projected to account for 22% of Asia Pacific revenue by 2035 and expand at 10.8% CAGR (2026-2035). Thailand, Vietnam, Indonesia, and other Southeast Asian markets combine processing capability with growing domestic demand from packaged foods and industrial uses. Export infrastructure and access to rice supply make the subregion strategically important to global specialty starch availability.
North America Rice Starch Market Analysis
North America generated USD 220 million in 2025 and is forecast to grow at 6.8% CAGR (2026-2035). The region is characterized by high-value demand from clean-label foods, certified-organic formulations, and pharmaceutical excipient procurement. Customer qualification processes and technical service requirements favor suppliers that can provide dependable documentation and multi-market distribution.
United States
The United States generated USD 185 million in 2025 and is projected to account for 85% of North American revenue by 2035. Demand comes from packaged-food reformulation, infant nutrition, pharmaceutical manufacturing, and organic product launches. Its scale makes the country a critical destination for suppliers able to meet demanding product, quality, and sourcing requirements.
Canada
Canada is projected to reach USD 64 million by 2035 and grow at 6.3% CAGR (2026-2035). The market reflects demand from natural products, clean-label food manufacturing, and pharmaceutical procurement, with ingredient buyers often seeking certified and traceable supply. Its smaller scale relative to the United States does not reduce its relevance to regional distributors and specialty suppliers.
Europe Rice Starch Market Analysis
Europe is projected to reach USD 371 million by 2035 and grow at 5.8% CAGR (2026-2035). The region's demand is shaped by mature food and pharmaceutical markets, rigorous compliance expectations, and established specialty starch supply chains. Regulatory readiness, organic certification, and formulation expertise remain important barriers to entry for suppliers targeting premium applications.
Germany
Germany generated USD 70 million in 2025 and is forecast to reach USD 130 million by 2035. Its importance stems from its role as a specialty ingredient consuming market, processing location, and distribution gateway to the wider European market. Demand is reinforced by food, pharmaceutical, and export-oriented supply chains that value proven quality assurance.
United Kingdom
The United Kingdom accounted for 18% of European revenue in 2025 and is projected to reach USD 66 million by 2035. Specialty food manufacturing, pharmaceutical excipient demand, and cosmetics formulation support the country's market position. Buyers' continued focus on compliance and clean-label product development sustains demand for differentiated starch grades.
France
France is projected to reach USD 55 million by 2035 and expand at 5.5% CAGR (2026-2035). Its quality-oriented food sector and sizeable cosmetics industry provide demand for natural, certified, and fine-particle ingredients. Procurement is likely to remain concentrated in applications where ingredient provenance and product performance both influence brand positioning.
Italy
Italy is expected to reach USD 42 million by 2035 and grow at 5.9% CAGR (2026-2035). Food processing, particularly in dairy, confectionery, and free-from categories, provides a stable base for rice starch use. The country's emphasis on premium food positioning supports demand for functional ingredients with clean-label compatibility.
Netherlands
The Netherlands is forecast to reach USD 37 million by 2035 and expand at 5.9% CAGR (2026-2035). Its logistics role supports regional redistribution, while domestic food and pharmaceutical industries provide end-use demand. Suppliers serving the country benefit from efficient access to wider European customer networks.
Spain
Spain held 8% of European revenue in 2025 and is expected to grow at 4.4% CAGR (2026-2035). Price sensitivity in food manufacturing limits faster replacement of commodity starch alternatives, although health-food and gluten-free categories provide an offset. Demand should remain strongest where product positioning justifies the functional or labeling advantages of rice starch.
Rest of Europe
Rest of Europe accounted for 5% of European revenue in 2025 and is forecast to expand at 5.4% CAGR (2026-2035). Growth is supported by food-processing modernization and increasing demand for qualified excipients across Central, Eastern, and Northern European markets. These countries offer incremental opportunity for suppliers with strong regional distribution capabilities.
Latin America Rice Starch Market Analysis
Latin America represented 8% of global revenue in 2025 and is projected to reach USD 141 million by 2035. The region's expansion is tied to food-processing industrialization and growing adoption of functional ingredients in packaged foods and pharmaceutical manufacturing. Demand development is more structurally driven than in mature premium-starch markets.
Brazil
Brazil generated USD 45 million in 2025 and is expected to grow at 7.2% CAGR (2026-2035). As the region's largest food-processing economy, it provides the broadest market for functional food ingredients and increasingly sophisticated quality requirements. Bakery, infant nutrition, and pharmaceutical uses offer particularly relevant demand channels.
Argentina
Argentina is projected to account for 16% of Latin American revenue by 2035 and grow at 6.0% CAGR (2026-2035). Dairy, confectionery, and processed-grain manufacturing support rice starch consumption, while economic volatility may influence purchasing patterns for imported specialty grades. Suppliers with flexible commercial models are better positioned to navigate this environment.
Colombia
Colombia generated USD 8 million in 2025 and is projected to reach USD 17 million by 2035. Packaged-food expansion and developing pharmaceutical manufacturing capacity support demand from a relatively early base. The market offers room for increased specialty starch penetration as local manufacturers broaden their formulation capabilities.
Rest of Latin America
Rest of Latin America is projected to reach USD 12 million by 2035 and grow at 10.2% CAGR (2026-2035). Food-processing investment and rising demand for pharmaceutical ingredients underpin the outlook across smaller markets. Growth will depend on distribution reach and the ability of suppliers to serve fragmented national procurement environments.
Middle East & Africa (MEA) Rice Starch Market Analysis
Middle East & Africa generated USD 44 million in 2025 and is projected to expand at 9.3% CAGR (2026-2035). Food-processing investment, pharmaceutical capacity development, and a comparatively low starting base support the region's outlook. Import logistics, local manufacturing policies, and distributor capabilities will determine where demand converts into sustained specialty-starch procurement.
Saudi Arabia
Saudi Arabia generated USD 22 million in 2025 and is forecast to grow at 10.3% CAGR (2026-2035). Food-security initiatives and investment in domestic food and pharmaceutical production support demand for functional ingredients. Its position as a regional import and processing hub also broadens the commercial significance of local capacity additions.
UAE
The UAE is projected to account for 26% of MEA revenue by 2035 and grow at 8.9% CAGR (2026-2035). Trade, re-export, and free-zone infrastructure make the country an important gateway for suppliers serving Gulf and adjacent markets. Demand extends beyond domestic manufacturing because of its role in regional distribution.
South Africa
South Africa generated USD 6 million in 2025 and is expected to expand at 8.0% CAGR (2026-2035). Its comparatively developed food-manufacturing sector and pharmaceutical base support demand for functional and clean-label ingredients. Premium retail categories provide an additional route for allergen-free and natural-positioned products.
Rest of MEA
Rest of MEA is projected to hold 8% of regional revenue by 2035 and grow at 9.4% CAGR (2026-2035). Early-stage food-processing development and investment in regional manufacturing hubs provide the underlying demand base. Market access will remain dependent on supplier logistics, local partnerships, and regulatory navigation.
GMI Analyst View
We expect Asia Pacific to remain the market's central production and demand engine because supply proximity and processing capacity reinforce one another. North America and Europe will continue to matter disproportionately for specialty value creation, while Middle East & Africa offers a higher-growth opportunity that will require patient channel development and locally relevant supply strategies.
Rice Starch Market Share & Competitive Landscape
The rice starch market share landscape remains fragmented, with the top five suppliers collectively accounting for approximately 33% of global revenue in 2025. This structure leaves substantial room for regional processors, especially in Asia, to compete in conventional grades, while larger and more specialized suppliers differentiate through technical support, traceability, regulatory infrastructure, and access to multinational customer accounts.
Ingredion Incorporated held 11% market share in 2025. Its competitive position is supported by a broad specialty-ingredient platform, established customer relationships, and technical-sales capabilities that enable it to serve multinational food and industrial buyers. The company is well placed where customers require consistent supply, formulation support, and multi-geography commercial coverage.
BENEO GmbH held 10% market share in 2025. Its differentiation rests on rice-focused processing capabilities, clean-label functionality, and a strong compliance and sustainability proposition for premium food, pharmaceutical, and personal care customers. Its traceable sourcing approach is aligned with customers seeking more credible ingredient-chain documentation.
JiangXi Golden Agriculture Biotech held 5% market share in 2025. The company reflects the progression of Chinese rice processors toward higher-value starch and derivative products, supported by domestic processing scale and growing export opportunities. Its relevance is increasing as buyers seek supply options across a broader group of Asian specialty-starch producers.
Bangkok Starch Industrial Co., Ltd. and Cargill, Incorporated maintain established competitive positions through export channels and broader ingredient-platform capabilities, respectively. Thai Flour Industry Co., Ltd., Herba Ingredients, Anhui Shunxin Shenyuan Biological Food Co., Ltd., WFM Starch Products, Burapa Prosper Co., Ltd., Sacchetto S.p.A., Shafi Gluco Chem (Pvt.) Ltd., Wuxi Jinnong Biotechnology Co., Ltd., and Angel Starch & Food Pvt. Ltd. add to the competitive intensity across regional food and industrial markets. AGRANA Beteiligungs-AG remains within the competitive scope, although its starch operations are concentrated in corn, wheat, and potato derivatives rather than rice starch.
Recent Industry Developments
BENEO's Sustainable Rice Platform initiative in Vietnam reached its first harvest in December 2025, advancing a traceable rice-supply program developed with Rikolto and CarbonFarm. The project connects sustainable rice cultivation with BENEO's ingredient-processing requirements and demonstrates how environmental verification can become part of supplier qualification for premium food, infant-nutrition, and cosmetics customers [4]BENEO GmbH. "Sustainable rice farming: BENEO's SRP project in Vietnam." blog.beneo.com.
Need a specific section of this report?
Purchase regional analysis, country-level analysis, company profiles, or any other segment-level insights separately
based on your research needs.
Frequently Asked Questions (FAQs):
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Industry journals, trade publications, and specialized media.
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 20+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →